Selective inhibitors of phosphodiesterases: therapeutic promise for neurodegenerative disorders

被引：15

作者：

Umar, Tarana ^{[1
]}

Hoda, Nasimul ^{[1
]}

机构：

[1] Cent Univ, Jamia Millia Islamia, Dept Chem, New Delhi 110025, India

来源：

MEDCHEMCOMM | 2015年 / 6卷 / 12期

关键词：

CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CAMP-SPECIFIC PHOSPHODIESTERASES; A-MEDIATED PHOSPHORYLATION; OBJECT RECOGNITION MEMORY; MESSENGER-RNA EXPRESSION; STRUCTURE-BASED DESIGN; PDE7; INHIBITORS; MOUSE MODEL;

D O I：

10.1039/c5md00419e

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Neurodegenerative disease appears as a result of genomic lesions which lead to alterations at multiple levels like genomic product and biological pathways. It involves destruction of existing neuroprotective mechanisms inside body which initiates the cellular changes involved in processing of these insidious disorders. Phosphodiesterases that are crucial for degradation of cAMP and cGMP have been puissant in memory retrieval. Overwhelming therapeutic credential of PDE5 inhibitors have triggered interests in PDE inhibitors. Almost every PDE member has marked its presence in the CNS devising them as enticing sources of novel protein targets for curing ND. This review describes a selection of recent findings and advancements with regards to PDE genes that are crucial for exploring pharmacological routes to ND.

引用

页码：2063 / 2080

页数：18

共 153 条

[1]

Abarghaz, 2005, Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase 2 inhibitors, preparation and therapeutic use thereof, Patent No. 2005063723

[2] Phosphodiesterase 4B (PDE4B) and cAMP-level regulation within different tissue fractions of rat hippocarnpal slices during long-terin potentiation in vitro [J].